Drug | LPS (1 mg/l) | Dose (μg/ml) | Proliferation inhibition rate (%) | IL-6 (pg/ml) | TNF-α (pg/ml) |
---|---|---|---|---|---|
Control | – | 0 | 47.4 ± 10.4 | 0.43 ± 0.17 | 0.35 ± 0.11 |
Model | + | 0 | 16.3 ± 4.6# | 1.59 ± 0.64# | 1.37 ± 0.37# |
Quercetin | + | 25 | 28.6 ± 5.3* | 0.98 ± 0.42* | 0.84 ± 0.38* |
+ | 50 | 34.2 ± 7.1* | 0.65 ± 0.29* | 0.63 ± 0.19* | |
+ | 100 | 43.8 ± 9.7* | 0.49 ± 0.18* | 0.48 ± 0.14* | |
kaempferide | + | 25 | 19.7 ± 7.9 | 1.33 ± 0.47 | 1.28 ± 0.41 |
+ | 50 | 31.1 ± 6.8* | 0.85 ± 0.36* | 0.89 ± 0.34* | |
+ | 100 | 39.9 ± 11.7* | 0.61 ± 0.19* | 0.67 ± 0.22* | |
Isorhamnetin | + | 25 | 18.5 ± 8.2 | 1.37 ± 0.44 | 1.23 ± 0.47 |
+ | 50 | 31.9 ± 9.8* | 0.89 ± 0.25* | 0.92 ± 0.33* | |
+ | 100 | 40.4 ± 11.3* | 0.64 ± 0.18* | 0.71 ± 0.29* |